Drug Shortage Report for PMS-IMATINIB

Last updated on 2020-06-10 History
Report ID 59113
Drug Identification Number 02431114
Brand name PMS-IMATINIB
Common or Proper name IMATINIB
Company Name PHARMASCIENCE INC
Market Status DORMANT
Active Ingredient(s) IMATINIB
Strength(s) 100MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 120
ATC code L01XE
ATC description OTHER ANTINEOPLASTIC AGENTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2018-07-30
Estimated end date Unknown
Actual end date 2020-06-09
Shortage status Resolved
Updated date 2020-06-10
Company comments Product to be discontinued.
Health Canada comments
Tier 3 Status No
Contact Address 6111 ROYALMOUNT AVE
MONTREAL, QUEBEC
CANADA H4P 2T4
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2018-08-24 English Compare
v2 2018-08-24 French Compare
v3 2018-08-25 English Compare
v4 2018-10-03 English Compare
v5 2018-10-03 French Compare
v6 2018-10-03 English Compare
v7 2018-10-03 French Compare
v8 2019-07-31 English Compare
v9 2019-07-31 French Compare
v10 2019-09-12 English Compare
v11 2019-09-12 French Compare
v12 2020-06-10 English Compare
v13 2020-06-10 French Compare

Showing 1 to 13 of 13